Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
February 5, 2021
Sponsor: BROUK
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
February 5, 2021
Sponsor: BROUK
Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations
May 1, 2023
Sponsor: FERNANDEZ
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
March 10, 2016
Sponsor: HANNON
Requires health insurers to provide coverage for opioid antagonists and devices
February 18, 2025
Sponsor: HARCKHAM
Requires health insurers to provide coverage for opioid antagonists and devices
March 3, 2023
Sponsor: HARCKHAM
Relates to availability of certain reports detailing sales of opioids in this state
January 6, 2023
Sponsor: HARCKHAM
Authorizes certain school nurses to administer an opioid antagonist
February 9, 2015
Sponsor: MARCHIONE
Relates to requiring homeless shelters to keep an opioid antagonist on hand, have at least one trained employee on duty at all times, and develop a training plan for opioid overdoses
March 14, 2025
Sponsor: CLEARE
Relates to requiring homeless shelters to keep an opioid antagonist on hand, have at least one trained employee on duty at all times, and develop a training plan for opioid overdoses
January 17, 2023
Sponsor: CLEARE
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
December 7, 2017
Sponsor: LANZA